Click here to get full coverage on BJDX SEC Filings - Bluejay Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

BJDX SEC Filings - Bluejay Diagnostics Inc 10-K, 10-Q, 8-K Forms  Stock Titan

BJDX SEC Filings - Bluejay Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Click here to get full coverage on Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split - Yahoo Finance

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split  Yahoo Finance

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split - Yahoo Finance

Click here to get full coverage on Director Fred S. Zeidman buys 12,500 Bluejay Diagnostics (BJDX) shares at $2.00 - Stock Titan

Director Fred S. Zeidman buys 12,500 Bluejay Diagnostics (BJDX) shares at $2.00  Stock Titan

Director Fred S. Zeidman buys 12,500 Bluejay Diagnostics (BJDX) shares at $2.00 - Stock Titan

Click here to get full coverage on Bluejay Diagnostics says all prefunded warrants exercised; ~972,000 shares outstanding, 1.5M cash-exercise warrants - TradingView

Bluejay Diagnostics says all prefunded warrants exercised; ~972,000 shares outstanding, 1.5M cash-exercise warrants  TradingView

Bluejay Diagnostics says all prefunded warrants exercised; ~972,000 shares outstanding, 1.5M cash-exercise warrants - TradingView

Click here to get full coverage on Bluejay Diagnostics director Svetlana Dey buys $25,000 in common stock By Investing.com - Investing.com Nigeria

Bluejay Diagnostics director Svetlana Dey buys $25,000 in common stock By Investing.com  Investing.com Nigeria

Bluejay Diagnostics director Svetlana Dey buys $25,000 in common stock By Investing.com - Investing.com Nigeria

Click here to get full coverage on Bluejay Diagnostics (BJDX) Stock Rockets on Expanded Partnership: A Game-Changer for Sepsis Testing? - RagingBull

Bluejay Diagnostics (BJDX) Stock Rockets on Expanded Partnership: A Game-Changer for Sepsis Testing?  RagingBull

Bluejay Diagnostics (BJDX) Stock Rockets on Expanded Partnership: A Game-Changer for Sepsis Testing? - RagingBull

Click here to get full coverage on Director Wurth Douglas Clark boosts Bluejay Diagnostics (BJDX) stake in $2 private share purchase - Stock Titan

Director Wurth Douglas Clark boosts Bluejay Diagnostics (BJDX) stake in $2 private share purchase  Stock Titan

Director Wurth Douglas Clark boosts Bluejay Diagnostics (BJDX) stake in $2 private share purchase - Stock Titan

Click here to get full coverage on Bluejay Diagnostics Provides First Quarter 2026 Corporate Update - Yahoo Finance

Bluejay Diagnostics Provides First Quarter 2026 Corporate Update  Yahoo Finance

Bluejay Diagnostics Provides First Quarter 2026 Corporate Update - Yahoo Finance

Click here to get full coverage on Bluejay Diagnostics director Donald Chase buys $25,000 in common stock By Investing.com - Investing.com Nigeria

Bluejay Diagnostics director Donald Chase buys $25,000 in common stock By Investing.com  Investing.com Nigeria

Bluejay Diagnostics director Donald Chase buys $25,000 in common stock By Investing.com - Investing.com Nigeria

Click here to get full coverage on Bluejay Diagnostics (NASDAQ: BJDX) CEO adds 12,500 shares in private placement - Stock Titan

Bluejay Diagnostics (NASDAQ: BJDX) CEO adds 12,500 shares in private placement  Stock Titan

Bluejay Diagnostics (NASDAQ: BJDX) CEO adds 12,500 shares in private placement - Stock Titan

Click here to get full coverage on Bluejay Diagnostics (BJDX) director buys 12,500 shares at $2 - Stock Titan

Bluejay Diagnostics (BJDX) director buys 12,500 shares at $2  Stock Titan

Bluejay Diagnostics (BJDX) director buys 12,500 shares at $2 - Stock Titan

Click here to get full coverage on Bluejay Diagnostics (BJDX) director buys 12,500 shares in placement - Stock Titan

Bluejay Diagnostics (BJDX) director buys 12,500 shares in placement  Stock Titan

Bluejay Diagnostics (BJDX) director buys 12,500 shares in placement - Stock Titan

Click here to get full coverage on Sepsis test maker builds supply for 10M rapid kits as key trial advances - Stock Titan

Sepsis test maker builds supply for 10M rapid kits as key trial advances  Stock Titan

Sepsis test maker builds supply for 10M rapid kits as key trial advances - Stock Titan

Click here to get full coverage on Bluejay fixes sepsis test production issues, keeps 510(k) plan in view - Stock Titan

Bluejay fixes sepsis test production issues, keeps 510(k) plan in view  Stock Titan

Bluejay fixes sepsis test production issues, keeps 510(k) plan in view - Stock Titan

Click here to get full coverage on Medical diagnostics firm ends prefunded warrants, flags 13G share confusion - Stock Titan

Medical diagnostics firm ends prefunded warrants, flags 13G share confusion  Stock Titan

Medical diagnostics firm ends prefunded warrants, flags 13G share confusion - Stock Titan

Click here to get full coverage on [SCHEDULE 13G/A] Bluejay Diagnostics, Inc. Amended Passive Investment Disclosure - Stock Titan

[SCHEDULE 13G/A] Bluejay Diagnostics, Inc. Amended Passive Investment Disclosure  Stock Titan

[SCHEDULE 13G/A] Bluejay Diagnostics, Inc. Amended Passive Investment Disclosure - Stock Titan

Click here to get full coverage on Bluejay Diagnostics (NASDAQ: BJDX) Q1 loss highlights urgent $20M funding need - Stock Titan

Bluejay Diagnostics (NASDAQ: BJDX) Q1 loss highlights urgent $20M funding need  Stock Titan

Bluejay Diagnostics (NASDAQ: BJDX) Q1 loss highlights urgent $20M funding need - Stock Titan

Click here to get full coverage on Bluejay Diagnostics (NASDAQ: BJDX) details Q1 2026 cash and sepsis test progress - Stock Titan

Bluejay Diagnostics (NASDAQ: BJDX) details Q1 2026 cash and sepsis test progress  Stock Titan

Bluejay Diagnostics (NASDAQ: BJDX) details Q1 2026 cash and sepsis test progress - Stock Titan

Click here to get full coverage on Bluejay nears finish line in sepsis test study with 624 patients - Stock Titan

Bluejay nears finish line in sepsis test study with 624 patients  Stock Titan

Bluejay nears finish line in sepsis test study with 624 patients - Stock Titan

Click here to get full coverage on Study explores link between ER inflammation marker and organ damage in sepsis - Stock Titan

Study explores link between ER inflammation marker and organ damage in sepsis  Stock Titan

Study explores link between ER inflammation marker and organ damage in sepsis - Stock Titan

Click here to get full coverage on Using the EWAVES Wave Finder to Catch Wave 5 Moves: Lessons from BJDX - Elliott Wave International

Using the EWAVES Wave Finder to Catch Wave 5 Moves: Lessons from BJDX  Elliott Wave International

Using the EWAVES Wave Finder to Catch Wave 5 Moves: Lessons from BJDX - Elliott Wave International

Click here to get full coverage on Bluejay Diagnostics director Fred S Zeidman buys $25,000 in shares By Investing.com - Investing.com Nigeria

Bluejay Diagnostics director Fred S Zeidman buys $25,000 in shares By Investing.com  Investing.com Nigeria

Bluejay Diagnostics director Fred S Zeidman buys $25,000 in shares By Investing.com - Investing.com Nigeria

Click here to get full coverage on Bluejay Diagnostics director Douglas Wurth buys $25,000 in stock By Investing.com - Investing.com Nigeria

Bluejay Diagnostics director Douglas Wurth buys $25,000 in stock By Investing.com  Investing.com Nigeria

Bluejay Diagnostics director Douglas Wurth buys $25,000 in stock By Investing.com - Investing.com Nigeria

Click here to get full coverage on Braeden Lichti Pushes for Changes at Bluejay Diagnostics with 3.65% Stake - TradingView

Braeden Lichti Pushes for Changes at Bluejay Diagnostics with 3.65% Stake  TradingView

Braeden Lichti Pushes for Changes at Bluejay Diagnostics with 3.65% Stake - TradingView

Click here to get full coverage on Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook - Yahoo Finance

Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook  Yahoo Finance

Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook - Yahoo Finance

Click here to get full coverage on Bluejay Diagnostics CEO Indranil Dey purchases $25,000 stock By Investing.com - Investing.com Nigeria

Bluejay Diagnostics CEO Indranil Dey purchases $25,000 stock By Investing.com  Investing.com Nigeria

Bluejay Diagnostics CEO Indranil Dey purchases $25,000 stock By Investing.com - Investing.com Nigeria

Click here to get full coverage on BJDX Technical Analysis & ETF Price Forecast - Intellectia AI

BJDX Technical Analysis & ETF Price Forecast  Intellectia AI

BJDX Technical Analysis & ETF Price Forecast - Intellectia AI

Click here to get full coverage on Bluejay Diagnostics completes prefunded warrant exercises - Investing.com

Bluejay Diagnostics completes prefunded warrant exercises  Investing.com

Bluejay Diagnostics completes prefunded warrant exercises - Investing.com

Click here to get full coverage on TradingKey - TradingKey

TradingKey - TradingKey

Click here to get full coverage on Bluejay Diagnostics CEO Indranil Dey purchases $25,000 stock By Investing.com - Investing.com Australia

Bluejay Diagnostics CEO Indranil Dey purchases $25,000 stock By Investing.com  Investing.com Australia

Bluejay Diagnostics CEO Indranil Dey purchases $25,000 stock By Investing.com - Investing.com Australia

Click here to get full coverage on Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Crowd Sentiment Stocks - Cổng thông tin điện tử tỉnh Lào Cai

Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Crowd Sentiment Stocks  Cổng thông tin điện tử tỉnh Lào Cai

Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Crowd Sentiment Stocks - Cổng thông tin điện tử tỉnh Lào Cai

Click here to get full coverage on Are insiders buying or selling Bluejay Diag (BJDX) Stock | Price at $1.95, Up 3.17% - Viral Momentum Stocks - Xã Vĩnh Công

Are insiders buying or selling Bluejay Diag (BJDX) Stock | Price at $1.95, Up 3.17% - Viral Momentum Stocks  Xã Vĩnh Công

Are insiders buying or selling Bluejay Diag (BJDX) Stock | Price at $1.95, Up 3.17% - Viral Momentum Stocks - Xã Vĩnh Công

Click here to get full coverage on Bluejay Diagnostics Completes 1-for-4 Reverse Stock Split - TipRanks

Bluejay Diagnostics Completes 1-for-4 Reverse Stock Split  TipRanks

Bluejay Diagnostics Completes 1-for-4 Reverse Stock Split - TipRanks

Click here to get full coverage on BJDX Forecast — Price Prediction for 2026. Should I Buy BJDX? - Intellectia AI

BJDX Forecast — Price Prediction for 2026. Should I Buy BJDX?  Intellectia AI

BJDX Forecast — Price Prediction for 2026. Should I Buy BJDX? - Intellectia AI

Click here to get full coverage on BJDX Stock Price and Chart — NASDAQ:BJDX - TradingView

BJDX Stock Price and Chart — NASDAQ:BJDX  TradingView

BJDX Stock Price and Chart — NASDAQ:BJDX - TradingView

Click here to get full coverage on Bluejay Diagnostics (BJDX) Stock News & Updates - Stock Titan

Bluejay Diagnostics (BJDX) Stock News & Updates  Stock Titan

Bluejay Diagnostics (BJDX) Stock News & Updates - Stock Titan

Click here to get full coverage on Pre-market Movers: NAOV, HZO, BJDX, PHLT... - RTTNews

Pre-market Movers: NAOV, HZO, BJDX, PHLT...  RTTNews

Pre-market Movers: NAOV, HZO, BJDX, PHLT... - RTTNews

Click here to get full coverage on Bluejay Diagnostics (BJDX) Stock Forecast and Price Target 2026 - MarketBeat

Bluejay Diagnostics (BJDX) Stock Forecast and Price Target 2026  MarketBeat

Bluejay Diagnostics (BJDX) Stock Forecast and Price Target 2026 - MarketBeat

Click here to get full coverage on What is the current Price Target and Forecast for Bluejay Diagnostics (BJDX) - Zacks Investment Research

What is the current Price Target and Forecast for Bluejay Diagnostics (BJDX)  Zacks Investment Research

What is the current Price Target and Forecast for Bluejay Diagnostics (BJDX) - Zacks Investment Research

Click here to get full coverage on Bluejay Diagnostics Stock Price Forecast. Should You Buy BJDX? - StockInvest.us

Bluejay Diagnostics Stock Price Forecast. Should You Buy BJDX?  StockInvest.us

Bluejay Diagnostics Stock Price Forecast. Should You Buy BJDX? - StockInvest.us

Click here to get full coverage on Technical Analysis of Bluejay Diagnostics, Inc. (NASDAQ:BJDX) - TradingView

Technical Analysis of Bluejay Diagnostics, Inc. (NASDAQ:BJDX)  TradingView

Technical Analysis of Bluejay Diagnostics, Inc. (NASDAQ:BJDX) - TradingView

Click here to get full coverage on BJDX Stock Price, Quote & Chart | BLUEJAY DIAGNOSTICS INC (NASDAQ:BJDX) - ChartMill

BJDX Stock Price, Quote & Chart | BLUEJAY DIAGNOSTICS INC (NASDAQ:BJDX)  ChartMill

BJDX Stock Price, Quote & Chart | BLUEJAY DIAGNOSTICS INC (NASDAQ:BJDX) - ChartMill

Click here to get full coverage on Bluejay Diagnostics (BJDX) Stock Price, News & Analysis - MarketBeat

Bluejay Diagnostics (BJDX) Stock Price, News & Analysis  MarketBeat

Bluejay Diagnostics (BJDX) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on Friday's after hours session: top gainers and losers - ChartMill

Friday's after hours session: top gainers and losers  ChartMill

Friday's after hours session: top gainers and losers - ChartMill

Click here to get full coverage on Unusual volume stocks in Wednesday's session - ChartMill

Unusual volume stocks in Wednesday's session  ChartMill

Unusual volume stocks in Wednesday's session - ChartMill

Click here to get full coverage on What's going on in today's after hours session - ChartMill

What's going on in today's after hours session  ChartMill

What's going on in today's after hours session - ChartMill

Click here to get full coverage on Jason Cook Net Worth (2026) - GuruFocus

Jason Cook Net Worth (2026) - GuruFocus

Click here to get full coverage on Bluejay Diagnostics (BJDX) Q4 2023 Earnings: Deeper-Than-Expected Losses as Development Spending Weighs on Results - Earnings Stability Report - Newser

Bluejay Diagnostics (BJDX) Q4 2023 Earnings: Deeper-Than-Expected Losses as Development Spending Weighs on Results - Earnings Stability Report  Newser

Bluejay Diagnostics (BJDX) Q4 2023 Earnings: Deeper-Than-Expected Losses as Development Spending Weighs on Results - Earnings Stability Report - Newser

Click here to get full coverage on Bluejay Diag (BJDX) Innovation Pipeline | Q4 2023: Profit Disappoints - Forward EPS - Newser

Bluejay Diag (BJDX) Innovation Pipeline | Q4 2023: Profit Disappoints - Forward EPS  Newser

Bluejay Diag (BJDX) Innovation Pipeline | Q4 2023: Profit Disappoints - Forward EPS - Newser

Click here to get full coverage on Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Momentum Surge Alerts - Newser

Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Momentum Surge Alerts  Newser

Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Momentum Surge Alerts - Newser

Click here to get full coverage on Bluejay Diag (BJDX) Innovation Pipeline | Q4 2023: Profit Disappoints - Pro Trader Recommendations - Newser

Bluejay Diag (BJDX) Innovation Pipeline | Q4 2023: Profit Disappoints - Pro Trader Recommendations  Newser

Bluejay Diag (BJDX) Innovation Pipeline | Q4 2023: Profit Disappoints - Pro Trader Recommendations - Newser

Click here to get full coverage on Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Tick Index - Newser

Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Tick Index  Newser

Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Tick Index - Newser

Click here to get full coverage on Are insiders buying or selling Bluejay Diag (BJDX) Stock | Price at $1.95, Up 3.17% - Investment Community Signals - Newser

Are insiders buying or selling Bluejay Diag (BJDX) Stock | Price at $1.95, Up 3.17% - Investment Community Signals  Newser

Are insiders buying or selling Bluejay Diag (BJDX) Stock | Price at $1.95, Up 3.17% - Investment Community Signals - Newser

Click here to get full coverage on Are insiders buying or selling Bluejay Diag (BJDX) Stock | Price at $1.95, Up 3.17% - Single Stock ETF - Newser

Are insiders buying or selling Bluejay Diag (BJDX) Stock | Price at $1.95, Up 3.17% - Single Stock ETF  Newser

Are insiders buying or selling Bluejay Diag (BJDX) Stock | Price at $1.95, Up 3.17% - Single Stock ETF - Newser

Click here to get full coverage on Are insiders buying or selling Bluejay Diag (BJDX) Stock | Price at $1.95, Up 3.17% - Trending Buy Opportunities - Newser

Are insiders buying or selling Bluejay Diag (BJDX) Stock | Price at $1.95, Up 3.17% - Trending Buy Opportunities  Newser

Are insiders buying or selling Bluejay Diag (BJDX) Stock | Price at $1.95, Up 3.17% - Trending Buy Opportunities - Newser

Click here to get full coverage on Bluejay Diag (BJDX) Innovation Pipeline | Q4 2023: Profit Disappoints - Profit Inflection Point - Newser

Bluejay Diag (BJDX) Innovation Pipeline | Q4 2023: Profit Disappoints - Profit Inflection Point  Newser

Bluejay Diag (BJDX) Innovation Pipeline | Q4 2023: Profit Disappoints - Profit Inflection Point - Newser

Click here to get full coverage on Bluejay Diagnostics, Inc. (BJDX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex

Bluejay Diagnostics, Inc. (BJDX) Stock Forecast & Price Prediction 2026–2030  CoinCodex

Bluejay Diagnostics, Inc. (BJDX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex

Click here to get full coverage on Bluejay Diagnostics Announces CTO Departure Effective May 30 - TipRanks

Bluejay Diagnostics Announces CTO Departure Effective May 30  TipRanks

BJDX

Price Chart

Key Statistics

Technicals

About BJDX

Latest News

BJDX SEC Filings - Bluejay Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split - Yahoo Finance

Director Fred S. Zeidman buys 12,500 Bluejay Diagnostics (BJDX) shares at $2.00 - Stock Titan

Advanced Charts

Top Gainers

Top Losers